Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

FORM 8.3 - WILLIS TOWERS WATSON PLC - AMENDMENT

17th Jul 2020 15:32

 

FORM 8.3

Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing15 July 2020

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,415,119

1.10%

446,818

0.35%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

565,000

0.44%

383,659

0.30%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

0

0.00%

0

0.00%

 

 

 

 

(4)

TOTAL:

 

 

 

 

1,980,119

1.54%

830,477

0.64%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

6

204.8700 USD
Purchase

7

205.8800 USD
Purchase

7

206.1100 USD
Purchase

11

205.9550 USD
Purchase

13

206.1900 USD
Purchase

14

205.7000 USD
Purchase

36

205.8558 USD
Purchase

49

205.7280 USD
Purchase

77

205.9990 USD
Purchase

114

205.8709 USD
Purchase

130

205.5195 USD
Purchase

223

205.8276 USD
Purchase

240

206.2350 USD
Purchase

300

205.8383 USD
Purchase

309

205.1919 USD
Purchase

326

206.2196 USD
Purchase

467

205.1200 USD
Purchase

2,238

204.8275 USD
Purchase

3,823

205.6230 USD
Purchase

4,199

206.1234 USD
Purchase

5,014

205.5719 USD
Purchase

5,503

206.1200 USD
Purchase

6,838

205.6971 USD
Purchase

11,266

205.7328 USD
Purchase

11,443

205.7448 USD
Sale

2

204.9600 USD
Sale

2

205.3100 USD
Sale

3

205.5300 USD
Sale

4

205.4525 USD
Sale

4

205.2275 USD
Sale

4

205.8800 USD
Sale

4

205.6400 USD
Sale

5

205.2900 USD
Sale

5

205.5400 USD
Sale

6

205.8450 USD
Sale

7

205.5728 USD
Sale

8

205.8100 USD
Sale

10

205.3530 USD
Sale

12

206.1233 USD
Sale

12

205.7400 USD
Sale

12

205.5666 USD
Sale

13

205.8500 USD
Sale

16

206.3075 USD
Sale

25

206.0476 USD
Sale

25

206.2060 USD
Sale

28

205.7871 USD
Sale

36

205.9488 USD
Sale

77

205.1200 USD
Sale

100

204.8100 USD
Sale

161

204.7527 USD
Sale

186

204.7366 USD
Sale

200

205.6800 USD
Sale

200

204.8750 USD
Sale

210

205.5722 USD
Sale

265

205.7764 USD
Sale

300

204.8791 USD
Sale

319

205.5858 USD
Sale

380

205.6236 USD
Sale

400

205.9949 USD
Sale

475

205.1365 USD
Sale

578

206.1168 USD
Sale

600

205.9042 USD
Sale

894

205.9832 USD
Sale

1,030

205.5069 USD
Sale

1,291

204.8318 USD
Sale

1,848

205.8679 USD
Sale

3,491

205.6581 USD
Sale

5,112

205.7982 USD
Sale

5,358

205.4968 USD
Sale

8,816

206.1200 USD
Sale

9,606

205.7214 USD
Sale

10,538

205.7242 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?NO
Date of disclosure:

17 Jul 2020

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

 

If a connected EFM, state nature of connection

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200717005357/en/

Copyright Business Wire 2020


Related Shares:

Barclays
FTSE 100 Latest
Value8,875.22
Change24.59